SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression

Nucleic Acids Research

Volumn 42, Issue 18, 2014, Pages 11433-11446

  Gjerstorff, Morten Frier ^a   Relster, Mette Marie ^a   Greve, Katrine Buch Viden ^a   Moeller, Jesper Bonnet ^a   Elias, Daniel ^a   Lindgreen, Jonas Nørrelund ^a   Schmidt, Steffen ^a   Mollenhauer, Jan ^a   Voldborg, Bjørn ^b   Pedersen, Christina Bøg ^a   Brückmann, Nadine Heidi ^a   Møllegaard, Niels Erik ^c   Ditzel, Henrik Jørn ^a,d  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; BMI1 PROTEIN, HUMAN; CHROMATIN; DNA; EZH2 PROTEIN, HUMAN; HISTONE; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; REPRESSOR PROTEIN; SYNOVIAL SARCOMA X BREAKPOINT PROTEINS; TUMOR PROTEIN;

ANTAGONISTS AND INHIBITORS; CELL NUCLEUS; CHEMISTRY; CHROMATIN; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MELANOMA; METABOLISM; PHYSIOLOGY; SPERMATOGENESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; CHROMATIN; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; MELANOMA; NEOPLASM PROTEINS; POLYCOMB REPRESSIVE COMPLEX 1; POLYCOMB REPRESSIVE COMPLEX 2; POLYCOMB-GROUP PROTEINS; REPRESSOR PROTEINS; SPERMATOGENESIS;

EID: 84922377030     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku852     Document Type: Article

References (51)

1. Mills, A. A. (2010) Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat. Rev. Cancer, 10, 669-682.
2. Richly, H., Aloia, L. And Di Croce, L. (2011) Roles of the Polycomb group proteins in stem cells and cancer. Cell Death Dis., 2, e204.
3. Wang, H., Wang, L., Erdjument-Bromage, H., Vidal, M., Tempst, P., Jones, R. S. And Zhang, Y. (2004) Role of histone H2A ubiquitination in Polycomb silencing. Nature, 431, 873-878.
4. Delest, A., Sexton, T. And Cavalli, G. (2012) Polycomb: A paradigm for genome organization from one to three dimensions. Curr. Opin. Cell Biol., 24, 405-414.
5. Bachmann, I. M., Halvorsen, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P. And Akslen, L. A. (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J. Clin. Oncol., 24, 268-273.
6. Collett, K., Eide, G. E., Arnes, J., Stefansson, I. M., Eide, J., Braaten, A., Aas, T., Otte, A. P. And Akslen, L. A. (2006) Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. Clin. Cancer Res., 12, 1168-1174.
7. Mimori, K., Ogawa, K., Okamoto, M., Sudo, T., Inoue, H. And Mori, M. (2005) Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases. Eur. J. Surg. Oncol., 31, 376-380.
8. He, X. T., Cao, X. F., Ji, L., Zhu, B., Lv, J., Wang, D. D., Lu, P. H. And Cui, H. G. (2009) Association between Bmi1 and clinicopathological status of esophageal squamous cell carcinoma. World J. Gastroenterol., 15, 2389-2394.
9. Richter, G. H., Plehm, S., Fasan, A., Rossler, S., Unland, R., Bennani-Baiti, I. M., Hotfilder, M., Lowel, D., von Luettichau, I., Mossbrugger, I. et al. (2009) EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proc. Natl Acad. Sci. U.S.A., 106, 5324-5329.
10. Dovey, J. S., Zacharek, S. J., Kim, C. F. And Lees, J. A. (2008) Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion. Proc. Natl Acad. Sci. U.S.A., 105, 11857-11862.
11. Suva, M. L., Riggi, N., Janiszewska, M., Radovanovic, I., Provero, P., Stehle, J. C., Baumer, K., Le Bitoux, M. A., Marino, D., Cironi, L. et al. (2009) EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res., 69, 9211-9218.
12. Abdouh, M., Facchino, S., Chatoo, W., Balasingam, V., Ferreira, J. And Bernier, G. (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J. Neurosci., 29, 8884-8896.
13. Godlewski, J., Nowicki, M. O., Bronisz, A., Williams, S., Otsuki, A., Nuovo, G., Raychaudhury, A., Newton, H. B., Chiocca, E. A. And Lawler, S. (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res., 68, 9125-9130.
14. Jagani, Z., Wiederschain, D., Loo, A., He, D., Mosher, R., Fordjour, P., Monahan, J., Morrissey, M., Yao, Y. M., Lengauer, C. Et al. (2010) The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells. Cancer Res., 70, 5528-5538.
15. Rizo, A., Olthof, S., Han, L., Vellenga, E., de Haan, G. And Schuringa, J. J. (2009) Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. Blood, 114, 1498-1505.
16. Kia, S. K., Gorski, M. M., Giannakopoulos, S. And Verrijzer, C. P. (2008) SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol. Cell. Biol., 28, 3457-3464.
17. Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Monch, K., Minucci, S., Porse, B. T., Marine, J. C. Et al. (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev., 21, 525-530.
18. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. And van Lohuizen, M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature, 397, 164-168.
19. Wu, Z. L., Zheng, S. S., Li, Z. M., Qiao, Y. Y., Aau, M. Y. And Yu, Q. (2010) Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ., 17, 801-810.
20. Wu, Z., Lee, S. T., Qiao, Y., Li, Z., Lee, P. L., Lee, Y. J., Jiang, X., Tan, J., Aau, M., Lim, C. Z. et al. (2011) Polycomb protein EZH2 regulates cancer cell fate decision in response to DNA damage. Cell Death Differ., 18, 1771-1779.
21. Li, H., Cai, Q., Wu, H., Vathipadiekal, V., Dobbin, Z. C., Li, T., Hua, X., Landen, C. N., Birrer, M. J., Sanchez-Beato, M. et al. (2012) SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK. Mol. Cancer Res., 10, 1462-1472.
22. Wu, Z., Min, L., Chen, D., Hao, D., Duan, Y., Qiu, G. And Wang, Y. (2011) Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma. PloS ONE, 6, e14648.
23. Stefansson, O. A. And Esteller, M. (2011) EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells. Breast Cancer Res., 13, 309-310.
24. Chagraoui, J., Hebert, J., Girard, S. And Sauvageau, G. (2011) An anticlastogenic function for the Polycomb Group gene Bmi1. Proc. Natl Acad. Sci. U.S.A., 108, 5284-5289.
25. Ismail, I. H., Andrin, C., McDonald, D. And Hendzel, M. J. (2010) BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair. J. Cell Biol., 191, 45-60.
26. Mihic-Probst, D., Kuster, A., Kilgus, S., Bode-Lesniewska, B., Ingold-Heppner, B., Leung, C., Storz, M., Seifert, B., Marino, S., Schraml, P. et al. (2007) Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int. J. Cancer, 121, 1764-1770.
27. McHugh, J. B., Fullen, D. R., Ma, L., Kleer, C. G. And Su, L. D. (2007) Expression of polycomb group protein EZH2 in nevi and melanoma. J. Cutan. Pathol., 34, 597-600.
28. Bachmann, I. M., Puntervoll, H. E., Otte, A. P. And Akslen, L. A. (2008) Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Mod. Pathol., 21, 583-590.
29. Clark, J., Rocques, P. J., Crew, A. J., Gill, S., Shipley, J., Chan, A. M., Gusterson, B. A. And Cooper, C. S. (1994) Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11. 2;q11. 2) translocation found in human synovial sarcoma. Nat. Genet., 7, 502-508.
30. Garcia, C. B., Shaffer, C. M., Alfaro, M. P., Smith, A. L., Sun, J., Zhao, Z., Young, P. P., VanSaun, M. N. And Eid, J. E. (2012) Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. Oncogene, 31, 2323-2334.
31. Inagaki, H., Nagasaka, T., Otsuka, T., Sugiura, E., Nakashima, N. And Eimoto, T. (2000) Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma. Mod. Pathol., 13, 482-488.
32. dos Santos, N. R., de Bruijn, D. R. And van Kessel, A. G. (2001) Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer, 30, 1-14.
33. Lubieniecka, J. M., de Bruijn, D. R., Su, L., van Dijk, A. H., Subramanian, S., van de Rijn, M., Poulin, N., van Kessel, A. G. And Nielsen, T. O. (2008) Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma. Cancer Res., 68, 4303-4310.
34. Su, L., Sampaio, A. V., Jones, K. B., Pacheco, M., Goytain, A., Lin, S., Poulin, N., Yi, L., Rossi, F. M., Kast, J. et al. (2012) Deconstruction of the SS18-SSX fusion oncoprotein complex: insights into disease etiology and therapeutics. Cancer Cell, 21, 333-347.
35. Kadoch, C. And Crabtree, G. R. (2013) Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell, 153, 71-85.
36. Barco, R., Garcia, C. B. And Eid, J. E. (2009) The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1. PloS ONE, 4, e5060.
37. Soulez, M., Saurin, A. J., Freemont, P. S. And Knight, J. C. (1999) SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex. Oncogene, 18, 2739-2746.
38. Garcia, C. B., Shaffer, C. M. And Eid, J. E. (2012) Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2. BMC Genomics, 13, 189.
39. dos Santos, N. R., Torensma, R., de Vries, T. J., Schreurs, M. W., de Bruijn, D. R., Kater-Baats, E., Ruiter, D. J., Adema, G. J., van Muijen, G. N. And van Kessel, A. G. (2000) Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res., 60, 1654-1662.
40. Kirkin, A. F., Dzhandzhugazyan, K. And Zeuthen, J. (1998) Melanoma-associated antigens recognized by cytotoxic T lymphocytes. APMIS, 106, 665-679.
41. Gjerstorff, M. F., Johansen, L. E., Nielsen, O., Kock, K. And Ditzel, H. J. (2006) Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy. Br. J. Cancer, 94, 1864-1873.
42. Mischo, A., Kubuschok, B., Ertan, K., Preuss, K. D., Romeike, B., Regitz, E., Schormann, C., de Bruijn, D., Wadle, A., Neumann, F. et al. (2006) Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer. Int. J. Cancer, 118, 696-703.
43. Choi, J. And Chang, H. (2012) The expression of MAGE and SSX, and correlation of COX2, VEGF, and survivin in colorectal cancer. Anticancer Res., 32, 559-564.
44. Tureci, O., Chen, Y. T., Sahin, U., Gure, A. O., Zwick, C., Villena, C., Tsang, S., Seitz, G., Old, L. J. And Pfreundschuh, M. (1998) Expression of SSX genes in human tumors. Int. J. Cancer, 77, 19-23.
45. Burns, J. S., Abdallah, B. M., Guldberg, P., Rygaard, J., Schroder, H. D. And Kassem, M. (2005) Tumorigenic heterogeneity in cancer stem cells evolved from long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res., 65, 3126-3135.
46. Pirrotta, V. And Li, H. B. (2012) A view of nuclear Polycomb bodies. Curr. Opin. Genet. Dev., 22, 101-109.
47. Bantignies, F., Roure, V., Comet, I., Leblanc, B., Schuettengruber, B., Bonnet, J., Tixier, V., Mas, A. And Cavalli, G. (2011) Polycomb-dependent regulatory contacts between distant Hox loci in Drosophila. Cell, 144, 214-226.
48. Vazquez, J., Muller, M., Pirrotta, V. And Sedat, J. W. (2006) The Mcp element mediates stable long-range chromosome-chromosome interactions in Drosophila. Mol. Biol. Cell, 17, 2158-2165.
49. Muller, J. And Verrijzer, P. (2009) Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr. Opin. Genet. Dev., 19, 150-158.
50. Li, H. B., Muller, M., Bahechar, I. A., Kyrchanova, O., Ohno, K., Georgiev, P. And Pirrotta, V. (2011) Insulators, not Polycomb response elements, are required for long-range interactions between Polycomb targets in Drosophila melanogaster. Mol. Cell. Biol., 31, 616-625.
51. Chen, X., Hiller, M., Sancak, Y. And Fuller, M. T. (2005) Tissue-specific TAFs counteract Polycomb to turn on terminal differentiation. Science, 310, 869-872.